Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parham Sadeghipour

Showing results (101-110 of 128) with videos related to

Pageof 13
Sort By:
Scientific Reports|December 28, 2024
Chorioretinal microvascular changes in slow flow coronary phenomenon: a multi-center studyMohammadHossein MozafaryBazargany, Elias Khalili Pour, Ali Shamsedini, et al.
Seminars in Thrombosis and Hemostasis|March 1, 2024
Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved IndicationsSina Rashedi, Christie M Greason, Parham Sadeghipour, et al.
The Journal of Tehran Heart Center|May 30, 2023
The Pragmatic Role of COVID-19 on the Thrombus Grade of Patients with Contemporary ST-Segment-Elevation Myocardial InfarctionAta Firouzi, Zahra Hosseini, Zeinab Norouzi, et al.
JACC. Cardiovascular Interventions|February 11, 2022
Balloon-Expandable Cheatham-Platinum Stents Versus Self-Expandable Nitinol Stents in Coarctation of Aorta: A Randomized Controlled TrialParham Sadeghipour, Bahram Mohebbi, Ata Firouzi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 8, 2025
Direct oral anticoagulants or warfarin in patients with left ventricular thrombus after ST-elevation myocardial infarction: a pilot trial and a prespecified meta-analysis of randomised trialsYaser Jenab, Parham Sadeghipour, Reza Mohseni-Badalabadi, et al.
Journal of the American College of Cardiology|October 1, 2025
Fibrinolytic Therapy for Thromboembolic Diseases: Approved Indications and Future DirectionsSina Rashedi, Hannah Leyva, Nada Hamade, et al.
JAMA Cardiology|October 19, 2022
Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High-risk Pulmonary Embolism: The CANARY Randomized Clinical TrialParham Sadeghipour, Yaser Jenab, Jamal Moosavi, et al.
The Lancet. Haematology|May 30, 2025
Optimising communication to patients with venous thromboembolism: development of a provider toolkitFrederikus A Klok, Scott C Woller, Aviva Schwartz, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 23, 2020
Management of ST-segment-elevation myocardial infarction during the coronavirus disease 2019 (COVID-19) outbreak: Iranian"247" National Committee's position paper on primary percutaneous coronary interventionParham Sadeghipour, Azita H Talasaz, Vahid Eslami, et al.
Medrxiv : the Preprint Server for Health Sciences|May 11, 2021
Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized TrialsAzita H Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, et al.
Pageof 13

Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
Scientific Reports|December 28, 2024
Chorioretinal microvascular changes in slow flow coronary phenomenon: a multi-center studyMohammadHossein MozafaryBazargany, Elias Khalili Pour, Ali Shamsedini, et al.
Seminars in Thrombosis and Hemostasis|March 1, 2024
Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved IndicationsSina Rashedi, Christie M Greason, Parham Sadeghipour, et al.
The Journal of Tehran Heart Center|May 30, 2023
The Pragmatic Role of COVID-19 on the Thrombus Grade of Patients with Contemporary ST-Segment-Elevation Myocardial InfarctionAta Firouzi, Zahra Hosseini, Zeinab Norouzi, et al.
JACC. Cardiovascular Interventions|February 11, 2022
Balloon-Expandable Cheatham-Platinum Stents Versus Self-Expandable Nitinol Stents in Coarctation of Aorta: A Randomized Controlled TrialParham Sadeghipour, Bahram Mohebbi, Ata Firouzi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 8, 2025
Direct oral anticoagulants or warfarin in patients with left ventricular thrombus after ST-elevation myocardial infarction: a pilot trial and a prespecified meta-analysis of randomised trialsYaser Jenab, Parham Sadeghipour, Reza Mohseni-Badalabadi, et al.
Journal of the American College of Cardiology|October 1, 2025
Fibrinolytic Therapy for Thromboembolic Diseases: Approved Indications and Future DirectionsSina Rashedi, Hannah Leyva, Nada Hamade, et al.
JAMA Cardiology|October 19, 2022
Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High-risk Pulmonary Embolism: The CANARY Randomized Clinical TrialParham Sadeghipour, Yaser Jenab, Jamal Moosavi, et al.
The Lancet. Haematology|May 30, 2025
Optimising communication to patients with venous thromboembolism: development of a provider toolkitFrederikus A Klok, Scott C Woller, Aviva Schwartz, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 23, 2020
Management of ST-segment-elevation myocardial infarction during the coronavirus disease 2019 (COVID-19) outbreak: Iranian"247" National Committee's position paper on primary percutaneous coronary interventionParham Sadeghipour, Azita H Talasaz, Vahid Eslami, et al.
Medrxiv : the Preprint Server for Health Sciences|May 11, 2021
Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized TrialsAzita H Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, et al.
Pageof 13